Montrium Inc.: federal grants and contributions: 6 agreements; $1.3M value; 1 departments; 3 programs.
Assay record ASY-CA-184W9VP1KT · Cite as: Assay Systems, “Montrium Inc.: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/montrium-inc/
The Connect platform is used to record and manage operational information for clinical trials. The project will add functionality that leverages AI and ML to the existing platform for predictive process, quality and risk management.
Extension of eTMF Navigator to include intelligent and predictive algorithms for the improved operational management and risk assessment of clinical trials and clinical trial documentation.
The TMF (Trial Master File) forms the basis for regulatory inspections of new drug marketing applications and contains all relevant documentation and data to demonstrate how a clinical trial was conducted. A new service line employing AI/ML technologies is being developed to provide expert TMF management, for optimized inspection readiness.
Montrium aims to increase export sales to Denmark, Japan and USA West Coast through increased sales and marketing efforts. The project will include a combination of in-person sales visits and online advertising.
The purpose of this CanExport SMEs agreement is to support small- and medium-sized enterprises (SMEs) for activities related to export market development that are part of an export business case for a specific target market, particularly where activities are targeting departmental priority markets and sectors.
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.